SCHOTT Pharma AG & Co. KGaA
1SXP.F News Today: Stay Updated with the Latest SCHOTT Pharma AG & Co. KGaA News in Real Time
Find 1SXP.F news now at Meyka AI. Stay informed with the latest SCHOTT Pharma AG & Co. KGaA stocks updates, including price news, market analysis, and expert insights.
BIIB.SW Stock Drops 4.36% on April 29 as Earnings Loom
BIIB.SW stock falls 4.36% to CHF141.03 on SIX ahead of earnings. Biogen Inc. faces headwinds with declining net income and mixed technical signals.
TAK Insider Buying: Ricci Gabriele Acquires 34,994 Shares April 29, 2026
Takeda Pharmaceutical insider Ricci Gabriele acquires 34,994 American Depositary Shares as Chief Data & Tech Officer on April 27, 2026.
Novartis Stock April 29: Trump Drug Pricing Reality Looms
Trump’s MFN drug pricing policy ties U.S. prices to international rates, pressuring pharma innovation and stock valuations over the next 18 months.
0503.HK Surges 40.9% in Pre-Market Trading on High Volume
Lansen Pharmaceutical (0503.HK) jumps 40.94% with 13.96M shares traded. HKSE pre-market analysis on volume surge.
ALPMY Astellas Pharma Earnings Beat: EPS Surges 70%
Astellas Pharma (ALPMY) crushed earnings with $0.33 EPS, beating estimates by 70%, and $3.38B revenue, up 3.14% on April 27.
Novartis Q1 Results Disappoint, Hit by Entresto Generic Competition
Novartis has reported a weaker-than-expected Q1 performance, with its results impacted by rising competition from generic versions of its blockbuster heart drug Entresto. The pharmaceutical giant, known for its strong global presence, is now facing pressure on revenue growth as key drugs begin to lose exclusivity. Investors are reacting cautiously as the earnings highlight both…
NSRX Insider Trade: Rubin Eyal CFO Share Options Filing April 28
Nasus Pharma CFO Rubin Eyal files initial ownership of 40,549 share options worth $306,550 on March 27, 2026.
UNIECOM.NS Earnings Beat: Strong Q4 Results Amid Market Pullback
Unicommerce eSolutions beats EPS by 37.5% and revenue by 9.9%, posting $0.66 EPS and $563.94M revenue in Q4 2026.
GSK plc (GSK) Earnings Preview April 29, 2026
GSK earnings preview for April 29, 2026. Analysts expect $1.17 EPS and $10.23B revenue. Review estimates and historical performance.